Page 2 - Read Online

Topic: Radiotherapy of Brain Metastases from Lung Cancer

Radiotherapy is widely used for the treatment of brain metastases

from lung cancer (both small and non-small cell). Survival after

development of brain metastases is poor. However, with the advances

in immunotherapy and molecular targeted therapies, some patients

may achieve a long-term survival even with disseminated disease. For

such patients, the neurotoxicity of whole brain radiotherapy (WBRT)

is of particular concern and there is a need to use more focused forms

of radiotherapy as radiosurgery, or hippocampal-sparing. In some

patients, radiotherapy of brain may be avoided. Others benefit from

radiotherapy in form of WBRT or radiosurgery or both. In this Special

Issue, we aim to present an available evidence as well as areas of

research on radiotherapy of brain metastases from lung cancer.

Radiotherapy is widely used for the treatment of brain metastases

from lung cancer (both small and non-small cell). Survival after

development of brain metastases is poor. However, with the advances

in immunotherapy and molecular targeted therapies, some patients

may achieve a long-term survival even with disseminated disease. For

such patients, the neurotoxicity of whole brain radiotherapy (WBRT)

is of particular concern and there is a need to use more focused forms

of radiotherapy as radiosurgery, or hippocampal-sparing. In some

patients, radiotherapy of brain may be avoided. Others benefit from

radiotherapy in form of WBRT or radiosurgery or both. In this Special

Issue, we aim to present an available evidence as well as areas of

research on radiotherapy of brain metastases from lung cancer.